BMS-986231 Uses, Dosage, Side Effects and more
BMS-986231 is under investigation in clinical trial NCT02819271 (A First-in-Human Study of the Safety of Single Continuous Intravenous (IV) Infusions of CXL-1427 for up to 48 Hours in Healthy Volunteers).
| Trade Name | BMS-986231 |
| Generic | Cimlanod |
| Cimlanod Other Names | BMS-986231, Cimlanod |
| Type | |
| Formula | C5H7NO4S |
| Weight | Average: 177.17 Monoisotopic: 177.009578883 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
